-
1.发明公开NEW 2-AZETIDINONE DERIVATIVES AS CHOLESTEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF HYPERLIPIDAEMIC CONDITIONS 审中-公开用于治疗高脂血症LEIDEN NEW -2-氮杂环丁酮衍生物ALS胆固醇吸收抑制剂
公开(公告)号：EP1896458A1
公开(公告)日：2008-03-12
申请号：EP06747951.9
申请日：2006-06-21
申请人： AstraZeneca AB
IPC分类号： C07D405/12 , A61K31/397 , A61P25/28 , A61P3/06 , A61P9/10
CPC分类号： C07K5/0806 , C07K5/0827
摘要： The invention relates to 2-azetidinone derivatives of formula (I) , including pharmaceutically acceptable salts, solvates and prodrugs thereof. The compounds inhibit cholesterol absorption and are useful in the treatment of hyperlipidaemic conditions. The invention also relates to processes for their manufacture and to pharmaceutical compositions containing them.
-
2.发明授权DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY 有权与胆固醇吸收锁效果DIPHENYLAZETIDINONDERIVATE
公开(公告)号：EP1699759B1
公开(公告)日：2010-10-20
申请号：EP04809133.4
申请日：2004-12-21
申请人： AstraZeneca AB
发明人： ALENFALK, Susanne , DAHLSTRÖM, Mikael , HUNEGNAW, Fana , KARLSSON, Staffan , LEMURELL, Malin , LINDQVIST, Ann-Margret , SKJÄRET, Tore , STARKE, Ingemar
IPC分类号： C07D205/08 , A61K31/397 , A61P3/06 , A61P9/10 , A61P25/28
CPC分类号： C07D205/08 , A61K38/00 , C07K5/06026 , C07K5/06078
摘要： Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
-
3.发明公开NEW 2-AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HYPERLIPIDAEMIC DISEASES 审中-公开用于治疗高脂血症LEIDEN NEW -2-氮杂环丁酮衍生物
公开(公告)号：EP1896408A1
公开(公告)日：2008-03-12
申请号：EP06747952.7
申请日：2006-06-21
申请人： AstraZeneca AB
IPC分类号： C07D205/08 , A61K31/397 , A61P25/28 , A61P3/06 , A61P9/10
CPC分类号： C07D205/08 , C07K5/0806 , C07K5/0827
摘要： The invention relates to novel 2-azetidinone derivatives of formula (I) and to pharmaceutically acceptable salts, solvates and prodrugs thereof . The compounds are cholesterol absorption inhibitors, useful in the treatment of hyperlipidaemic conditions. The invention also relates to processes for their manufacture and to pharmaceutical compositions containing them.
-
4.发明公开DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY 有权二苯并二氮杂酮衍生物具有胆固醇吸收抑制活性
公开(公告)号：EP1699759A1
公开(公告)日：2006-09-13
申请号：EP04809133.4
申请日：2004-12-21
申请人： AstraZeneca AB
发明人： ALENFALK, Susanne , DAHLSTRÖM, Mikael , HUNEGNAW, Fana , KARLSSON, Staffan , LEMURELL, Malin , LINDQVIST, Ann-Margret , SKJÄRET, Tore , STARKE, Ingemar
IPC分类号： C07D205/08 , A61K31/397 , A61P3/06 , A61P9/10 , A61P25/28
CPC分类号： C07D205/08 , A61K38/00 , C07K5/06026 , C07K5/06078
摘要： Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 描述了式（I）化合物（其中可变基团如上定义）药学上可接受的盐，溶剂化物，这些盐的溶剂化物和前药以及它们作为胆固醇吸收抑制剂用于治疗高脂血症的用途。 还描述了它们的制造方法和含有它们的药物组合物。
-
5.发明公开NOVEL 2-AZETIDINONE DERIVATIVES AND THEIR USE AS CHOLESTEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF HYPERLIPIDAEMIA 审中-公开NEW -2-氮杂环丁酮衍生物及其作为胆固醇吸收抑制剂用于治疗高脂血症的用途
公开(公告)号：EP1896407A1
公开(公告)日：2008-03-12
申请号：EP06747933.7
申请日：2006-06-19
申请人： AstraZeneca AB
发明人： ALENFALK, Susanne , DAHLSTRÖM, Mikael , HUNEGNAW, Fana , KARLSSON, Staffan , LEMURELL, Malin , LINDQVIST, Ann-Margret , SKJÄRET, Tore , STARKE, Ingemar
IPC分类号： C07D205/08 , A61K31/397 , A61P3/06
CPC分类号： C07D205/08 , C07K5/06026
摘要： Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
-
6.发明公开NOVEL 2-AZETIDINONE DERIVATIVES AS CHOLESTEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF HYPERLIPIDAEMIC CONDITIONS 审中-公开新型2-氮杂二酮衍生物作为胆固醇吸收抑制剂治疗高脂血症
公开(公告)号：EP1896410A1
公开(公告)日：2008-03-12
申请号：EP06747954.3
申请日：2006-06-21
申请人： AstraZeneca AB
发明人： ALENFALK, Susanne , DAHLSTRÖM, Mikael , HUNEGNAW, Fana , KARLSSON, Staffan , LEMURELL, Malin , STARKE, Ingemar
IPC分类号： C07D205/08 , A61K31/397 , A61P25/28 , A61P3/06 , A61P9/10 , C07D405/12
CPC分类号： C07D205/08 , C07D405/12 , C07D405/14 , C07K5/06026
摘要： Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 描述了式（I）化合物:(其中可变基团如上定义）药学上可接受的盐，溶剂化物，此类盐的溶剂化物和前药以及它们作为胆固醇吸收抑制剂用于治疗高脂血症的用途。 还描述了它们的制造方法和含有它们的药物组合物。
-
7.发明公开NOVEL 2-AZETIDINONE DERIVATIVES AS CHOLESTEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF HYPERLIPIDAEMIC CONDITIONS 审中-公开NEW -2-氮杂环丁酮的胆固醇吸收抑制剂，作为高脂血症莱顿治疗
公开(公告)号：EP1896459A1
公开(公告)日：2008-03-12
申请号：EP06747955.0
申请日：2006-06-21
申请人： AstraZeneca AB
IPC分类号： C07D405/12 , A61K31/397 , A61P25/28 , A61P3/06 , A61P9/10
CPC分类号： C07D405/12
摘要： Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
-
8.发明公开NEW 2-AZETIDINONE DERIVATIVES USEFUL IN THE TREATMENT OF HYPERLIPIDAEMIC CONDITIONS 审中-公开为罹患高脂血症合适的新-2-氮杂环丁酮衍生物的治疗
公开(公告)号：EP1896457A1
公开(公告)日：2008-03-12
申请号：EP06747950.1
申请日：2006-06-21
申请人： AstraZeneca AB
IPC分类号： C07D405/12 , A61K31/397 , A61P25/28 , A61P9/10
CPC分类号： C07K5/0827 , C07K5/0806
摘要： The invention relates to compounds of formula (I) and pharmaceutically acceptable salts, solvates, and prodrugs thereof, and to their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia. The invention also relates to processes for their manufacture and pharmaceutical compositions containing them.
-
9.发明公开DIPHENYLAZETIDINONE DERIVATES PROCESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY 审中-公开与胆固醇吸收锁效果DIPHENYLAZETIDINONDERIVATE
公开(公告)号：EP1699758A1
公开(公告)日：2006-09-13
申请号：EP04809132.6
申请日：2004-12-21
申请人： AstraZeneca AB
发明人： ALENFALK, Susanne , DAHLSTRÖM, Mikael , HUNEGNAW, Fana , KARLSSON, Staffan , LEMURELL, Malin , LINDQVIST, Ann-Margret , SKJÄRET, Tore , STARKE, Ingemar
IPC分类号： C07D205/08 , A61K31/397 , A61P3/06 , A61P9/10 , A61P25/28
CPC分类号： C07D205/08
摘要： Compounds of formula (XV): [Chemical formula should be inserted here. Please see paper copy] (XV) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.022 秒)
